Aflibercept in combination with FOLFIRI for the 2nd-line treatment of patients with metastatic colorectal cancer (MCRC): safety data from a single institute experience-MedSci.cn

Aflibercept in combination with FOLFIRI for the 2nd-line treatment of patients with metastatic colorectal cancer (MCRC): safety data from a single institute experience

Muntoni, M; Aloi, MB; Capra, D; Defraia, E; Dettori, M; Mascia, L; Lanzillo, AM

ANNALS OF ONCOLOGY, 2017; 28 ( ):

科室
- - 订阅+
  - 更多科室
工具
服务